Close Menu

NEW YORK, Oct. 19 – The National Institute of Standards and Technology’s Advanced Technology Program has awarded RheoGene of Charlottesville, Va., a three-year, $2 million grant for gene-targeting technology, the company said.

RheoGene said it would use the funding to improve its gene-targeting technology, which is designed to allow researchers to insert and delete gene sequences in nuclear and mitochondrial genomes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.